Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fluvastatin: effects beyond cholesterol lowering.

A Corsini1

  • 1Institute of Pharmacological Sciences, University of Milan, Milan, Italy.

Journal of Cardiovascular Pharmacology and Therapeutics
|January 11, 2001
PubMed
Summary

Fluvastatin, a cholesterol-lowering statin, offers cardiovascular benefits beyond lipid reduction. Its pleiotropic effects, including anti-inflammatory and antithrombotic actions, contribute to slowing coronary heart disease progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma PCSK9 levels in children and adolescents: evidence from an Italian outpatient paediatric clinic cohort at cardio-metabolic risk.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2026
Same author

Effect of a homemade diet compared to a commercial diet on glycaemic variability and glycaemic control assessed by continuous glucose monitoring system in diabetic dogs: a randomised crossover study.

The Journal of small animal practice·2025
Same author

Differential effects of traditional cigarette, electronic cigarette, and tobacco heating product on human vascular smooth muscle cell phenotypic switch: A comparative functional perspective.

Atherosclerosis·2025
Same author

Simvastatin ameliorates senescence-induced mitochondrial dysfunction in vascular smooth muscle cells.

Atherosclerosis·2025
Same author

Updates in Small Interfering RNA for the Treatment of Dyslipidemias.

Current atherosclerosis reports·2023
Same author

Aorto-septal angle, isolated basal septal hypertrophy, and systolic murmur in 122 cats.

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2023

Area of Science:

  • Cardiology
  • Pharmacology
  • Biochemistry

Background:

  • Coronary heart disease (CHD) is a significant health concern, with cholesterol-lowering therapies as a primary treatment.
  • Fluvastatin, a statin, is approved for hypercholesterolemia and has demonstrated efficacy and safety.
  • Emerging data suggest fluvastatin impacts CHD progression and cardiovascular events in secondary prevention.

Purpose of the Study:

  • To review experimental evidence on fluvastatin's antiatherosclerotic and antithrombotic effects.
  • To explore non-lipid-lowering (pleiotropic) mechanisms contributing to fluvastatin's cardiovascular benefits.
  • To understand how fluvastatin modulates the mevalonate pathway for therapeutic outcomes.

Main Methods:

  • Review of experimental studies and clinical trial data on fluvastatin.
  • Analysis of fluvastatin's impact on molecular and cellular pathways involved in atherosclerosis.
  • Investigation of effects on inflammatory markers, lipoprotein oxidation, and cellular processes.

Main Results:

  • Fluvastatin demonstrates antiatherosclerotic effects, including reduced monocyte adhesion molecule expression and leukocyte-endothelial adherence.
  • Pleiotropic actions like inhibiting low-density lipoprotein oxidation and smooth muscle cell proliferation contribute to its benefits.
  • Fluvastatin exhibits antithrombotic effects via plaque stabilization and modulation of platelet activity and endothelial function.

Conclusions:

  • Fluvastatin's therapeutic effects extend beyond cholesterol lowering, involving significant pleiotropic actions.
  • These non-lipid-related mechanisms contribute to slowing CHD progression and reducing cardiovascular events.
  • Fluvastatin's modulation of the mevalonate pathway underlies its multifaceted cardiovascular protective effects.

Related Experiment Videos